IDENTIFICATION OF ISLET CAPACITY IN DONOR’S PANCREAS USING IMMUNOMORPHOLOGICAL ANALYSIS
https://doi.org/10.15825/1995-1191-2016-1-32-37
Abstract
The aim of the work was detailed morphological investigations of donor pancreas (DP) for the study of possibilities of maximal selection of islet tissue suitable for transplantation to a patient of diabetes mellitus type 1.
Materials and methods. Eight DPs were received as a result of multiorgan donation. Morphological investigations were performed by means of histological and special immunohistochemical methods.
Results. The Majority of islets were revealed in the tail part of the DP. Besides typical Langerhans islets with predominance of mosaically located beta cells, the accumulations of islet cells forming so-called interlobular (perilobular) islets were revealed in the layers of interlobular connecting tissue. In addition, in the cells of ductal epithelium nestin which is a marker of progenitor cells was revealed.
Conclusion. To obtain the maximal potential of islet tissue from DP it is necessary to use interlobular located islets as well as to use progenitor cells of pancreas, which have the ability to transdifferentiate into islet cells.
About the Authors
N. N. Skaletskiy
V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs
of the Ministry of Healthcare of the Russian Federation
Russian Federation
1, Shchukinskaya St., Moscow, 123182
Russian Federation
1, Shchukinskaya St., Moscow, 123182
L. A. Kirsanova
V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs
of the Ministry of Healthcare of the Russian Federation
Russian Federation
Moscow
Russian Federation
Moscow
G. N. Bubentsova
V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs
of the Ministry of Healthcare of the Russian Federation
Russian Federation
Moscow
Russian Federation
Moscow
N. V. Baranova
V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs
of the Ministry of Healthcare of the Russian Federation
Russian Federation
Moscow
Russian Federation
Moscow
G. N. Skaletskaya
V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs
of the Ministry of Healthcare of the Russian Federation
Russian Federation
Moscow
Russian Federation
Moscow
V. I. Sevastianov
V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs
of the Ministry of Healthcare of the Russian Federation
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Barton FB, Rickels MR, Alejandro R, Hering BJ, Wease S, Naziruddin B et al. Improvement in outcomes of clinical islet transplantation: 1999–2010. Diabetes Care. 2012 Jul; 35 (7): 1436–1445. doi: 10.2337/dc12-0063.
2. Balamurugan AN, Naziruddin B, Lockridge A, Tiwari M, Loganathan G, Takita M et al. Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999–2010. Am J Transplant. 2014 Nov; 14 (11): 2595–2606. doi: 10.1111/ajt.12872. Epub 2014 Oct 2.
3. Скалецкий НН, Кирсанова ЛА, Севастьянов ВИ. Разработка и экспериментальное исследование тканеинженерных конструкций поджелудочной железы из культур островковых клеток поджелудочной железы и биодеградируемых носителей с целью стимуляции регенерации β-клеток у больных сахарным диабетом. Трансплантология: итоги и перспективы. 2013; V: 140–152. Skaletskiy NN, Kirsanova LA, Sevastyanov VI. Development and experimental research cell-engineering constructs from cultures of pancreatic islet cells and biodegradable scaffolds in order to stimulate the regeneration of β-cells in patients with diabetes. Transplantation: results and prospects. 2013; V: 140–152.
4. Тимофеев АВ. Клеточно-популяционная организация поджелудочной железы и применение клеточных технологий в лечении сахарного диабета. Биология стволовых клеток и клеточные технологии. 2009; 2: 253–310. Timofeev AV. A cell-population structure of the pancreas and the use of cellular technology in the treatment of diabetes. Stem cell biology and cellular technologies. 2009; 2: 253–310.
5. Merkwitz C, Blaschuk OW, Schulz A. The ductal origin of structural and functional heterogeneity between pancreatic islets. Prog. Histochem. Cytochem. 2013 Oct; 48 (3): 103–140. DOI: 10.1016/j.proghi. 2013.09.001. PMID: 24100070.
6. Shimoda M, Chen S, Noduchi H, Matsumoto S, Grayburn PA. Neurogenic differentiation of cytokeratin-19-positive human pancreatic nonendocrine cells into insulin-producing cells. Transplantation Proceedings. 2010; 42 (6): 2071–2074. DOI: 10.1016/j.transproceed. 2010.05.114. PMID: 20692411.
7. Lardon J, Rooman I, Bouwens L. Nestin expression in pancreatic stellate cells and angiogenic endothelial cells. Histochem. Cell Biol. 2002; 117 (6): 535–540. RMID: 12107504.
8. Zulewski H, Abraham EJ, Gerlach MJ, Daniel PhB, Moritz W, Muller B. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes. 2001; 50 (3): 521–533. PMID: 11246871.
9. Mari-Engler SS, Correa-Giannella ML, Labriola L, Krogh K, Colin C. Co-localization of nestin and insulin and expression of islet cell markers in long-term human pancreatic nestin-positive cell cultures. J Endocrinol. 2004; 183 (3): 455–467. PMID: 15590972.
10. Fiorina P, Shapiro AMJ, Ricordi C, Secchi A. The clinical impact of islet transplantation. Am J of Transplantation. 2008; 8 (8): 1990–1997. DOI: 10.1111/j.1600-6143. 2008.02353.x. PMID: 18828765.
Review
For citations:
Skaletskiy N.N., Kirsanova L.A., Bubentsova G.N., Baranova N.V., Skaletskaya G.N., Sevastianov V.I. IDENTIFICATION OF ISLET CAPACITY IN DONOR’S PANCREAS USING IMMUNOMORPHOLOGICAL ANALYSIS. Russian Journal of Transplantology and Artificial Organs. 2016;18(1):32-37. (In Russ.) https://doi.org/10.15825/1995-1191-2016-1-32-37
Views:
1393
Email this article 